These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8301559)

  • 1. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.
    Nambi P; Pullen M; Spielman W
    J Pharmacol Exp Ther; 1994 Jan; 268(1):202-7. PubMed ID: 8301559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I]-BQ3020, a potent ETB-selective agonist, displays species differences in its binding characteristics.
    Nambi P; Pullen M
    Neuropeptides; 1995 Mar; 28(3):191-6. PubMed ID: 7791962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8- 21), [125I]IRL 1620.
    Watakabe T; Urade Y; Takai M; Umemura I; Okada T
    Biochem Biophys Res Commun; 1992 Jun; 185(3):867-73. PubMed ID: 1320877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suc-[Glu9,Ala11,15]-endothelin-1 (8-21), IRL 1620, identifies two populations of ET(B) receptors in guinea-pig bronchus.
    Mazzoni MR; Breschi MC; Ceccarelli F; Lazzeri N; Giusti L; Nieri P; Lucacchini A
    Br J Pharmacol; 1999 Jul; 127(6):1406-14. PubMed ID: 10455290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.
    Harada N; Himeno A; Shigematsu K; Sumikawa K; Niwa M
    Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
    Russell FD; Davenport AP
    Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between guanine nucleotide effect and reversible binding property of endothelin analogs.
    Nambi P; Pullen M; Aiyar N
    Neuropeptides; 1996 Feb; 30(1):109-14. PubMed ID: 8868308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ETB receptor subtypes using linear and truncated analogs of ET.
    Nambi P; Pullen M; Brooks DP; Gellai M
    Neuropeptides; 1995 Dec; 29(6):331-6. PubMed ID: 8837960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
    Semler DE; Ohlstein EH; Nambi P; Slater C; Stern PH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1052-8. PubMed ID: 7891315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
    Chin MH; Cioffi CL; Garay M; Neale RF; Shetty SS; DelGrande D; Mugrage B; Sills MA; Lipson KE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):74-83. PubMed ID: 8558459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor.
    Takai M; Umemura I; Yamasaki K; Watakabe T; Fujitani Y; Oda K; Urade Y; Inui T; Yamamura T; Okada T
    Biochem Biophys Res Commun; 1992 Apr; 184(2):953-9. PubMed ID: 1315540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for ETA and ETB receptors in rat skin and an investigation of their function in the cutaneous microvasculature.
    Lawrence E; Siney L; Wilsoncroft P; Knock GA; Terenghi G; Polak JM; Brain SD
    Br J Pharmacol; 1995 Jul; 115(5):840-4. PubMed ID: 8548185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
    Jarvis MF; Assal AA; Gessner G
    Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
    Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
    Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
    Nambi P; Wu HL; Pullen M; Aiyar N; Bryan H; Elliott J
    Mol Pharmacol; 1992 Aug; 42(2):336-9. PubMed ID: 1325032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.
    Fujitani Y; Ueda H; Okada T; Urade Y; Karaki H
    J Pharmacol Exp Ther; 1993 Nov; 267(2):683-9. PubMed ID: 7504100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500.
    Balwierczak JL; Bruseo CW; DelGrande D; Jeng AY; Savage P; Shetty SS
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S393-6. PubMed ID: 8587424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual control of seminiferous tubule contractility mediated by ETA and ETB endothelin receptor subtypes.
    Tripiciano A; Palombi F; Ziparo E; Filippini A
    FASEB J; 1997 Mar; 11(4):276-86. PubMed ID: 9068617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.